International Drug Discovery & Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 9.73 M
as on 05-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -48.77%
(FY 2019)
- Profit -64.81%
(FY 2019)
- Ebitda -6252.64%
(FY 2019)
- Net Worth -58.94%
(FY 2019)
- Total Assets -63.67%
(FY 2019)
About International Drug Discovery & Clinical Research
The Corporate was formerly known as Laxai Clinical Research Private Limited. The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.73 M, as per Ministry of Corporate Affairs (MCA) records.
Ahamed Zackriyah and Vasudevan Vijayalakshmi serve as directors at the Company.
- CIN/LLPIN
U73100TG2009PTC065747
- Company No.
065747
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2009
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does International Drug Discovery & Clinical Research Private Limited offer?
International Drug Discovery & Clinical Research Private Limited offers a wide range of products and services, including Corporate Training, Online Education Consultancy Services, E-Learning Solution.
Who are the key members and board of directors at International Drug Discovery & Clinical Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahamed Zackriyah  | Director | 27-Aug-2015 | Current |
| Vasudevan Vijayalakshmi | Director | 27-Aug-2015 | Current |
Financial Performance of International Drug Discovery & Clinical Research.
International Drug Discovery & Clinical Research Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 48.77% decrease. The company also saw a substantial fall in profitability, with a 64.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 58.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of International Drug Discovery & Clinical Research?
In 2019, International Drug Discovery & Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at International Drug Discovery & Clinical Research?
Unlock and access historical data on people associated with International Drug Discovery & Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of International Drug Discovery & Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped International Drug Discovery & Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
